Zura Bio Ltd
ZURA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855644
No open-market purchases or sales by Zura Bio Ltd insiders were filed in the last 90 days; 95 institutions reported holding it in 13F filings for Q2 2026, worth $428.9M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Zura Bio Ltd changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 0 | 17 | +17 |
| Shares | 0 | 3.21M | +3.21M |
| Value | $0 | $31.6M | +$31.6M |
New holders (17)
Institutions that held Zura Bio Ltd at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Hudson Bay Capital Management LP | 1,188,000 | $11.7M | 0.16% |
| Boussard & Gavaudan Investment Management LLP | 375,000 | $3.68M | 0.34% |
| Spring Creek Capital LLC | 300,000 | $2.95M | 0.15% |
| UBS Oconnor LLC | 250,979 | $2.47M | 0.02% |
| Radcliffe Capital Management, L.P. | 250,000 | $2.46M | 0.10% |
| Polar Asset Management Partners Inc. | 200,000 | $1.97M | 0.02% |
| Oaktree Capital Management LPSuperinvestorOaktree Capital | 150,000 | $1.47M | 0.02% |
| Berkley W R Corp | 121,016 | $1.18M | 0.08% |
| Gabelli Funds LLC | 108,600 | $1.06M | 0.01% |
| Gabelli & Co Investment Advisers, Inc. | 91,400 | $894.0K | 0.11% |
| Glazer Capital, LLC | 65,708 | $642.0K | 0.01% |
| Highland Capital Management Fund Advisors, L.P. | 31,000 | $306.0K | 0.05% |
| Basso Capital Management, L.P. | 25,000 | $247.0K | 0.03% |
| CVI Holdings, LLC | 24,600 | $241.0K | 0.02% |
| Schonfeld Strategic Advisors LLC | 20,000 | $197.0K | 0.00% |
| Warberg Asset Management LLC | 10,000 | $99.0K | 0.03% |
| Wolverine Asset Management LLC | 105 | $1.00K | 0.00% |
Sold out (0)
Institutions that held Zura Bio Ltd at the end of Q2 2021 and filed for Q3 2021 without it.
None.